SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder.
Journal
Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
30
05
2022
received:
17
02
2022
accepted:
01
06
2022
pubmed:
18
6
2022
medline:
18
8
2022
entrez:
17
6
2022
Statut:
ppublish
Résumé
SARS-COV-2 frequently cause neurological disorders and is sometimes associated with onset of autoimmune diseases affecting the nervous system. Over recent years, a rare but distinct diagnosis designated myelin oligodendrocyte glycoprotein-associated disorder (MOGAD) has been recognized in patients with attacks of optic neuritis, myelitis, or encephalomyelitis and increased levels of anti-MOG antibodies. The cause of MOGAD is unknown. However, there have been reports of single cases of MOGAD in patients with Covid-19 infection. We report a series of SARS-CoV-2 positive patients that developed MOGAD, but a homology search did not support a cross-reactive immune response to SARS-CoV-2 spike-protein and MOG.
Identifiants
pubmed: 35713508
doi: 10.1002/acn3.51609
pmc: PMC9349599
doi:
Substances chimiques
Autoantibodies
0
Myelin-Oligodendrocyte Glycoprotein
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1296-1301Informations de copyright
© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Références
Mult Scler Relat Disord. 2020 Sep;44:102324
pubmed: 32615528
Curr Biol. 2020 Apr 20;30(8):1578
pubmed: 32315626
Mult Scler Relat Disord. 2017 Oct;17:148-150
pubmed: 29055448
Pediatr Neurol. 2021 Nov;124:40-41
pubmed: 34509727
Front Neurol. 2020 Jun 23;11:715
pubmed: 32655490
Clin Pediatr (Phila). 2021 Nov;60(13):501-503
pubmed: 34344226
Eur J Neurol. 2022 Jun;29(6):1855-1858
pubmed: 35224824
BMC Neurol. 2017 Apr 19;17(1):76
pubmed: 28420330
Lancet Neurol. 2021 Sep;20(9):762-772
pubmed: 34418402
Medicine (Baltimore). 2021 May 14;100(19):e25865
pubmed: 34106635
Neurol Neuroimmunol Neuroinflamm. 2020 Jun 10;7(5):
pubmed: 32522768
J Child Neurol. 2017 Oct;32(12):996-999
pubmed: 28820014
Autoimmun Rev. 2020 Aug;19(8):102597
pubmed: 32535093
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620976018
pubmed: 33238757
Mult Scler Relat Disord. 2020 Nov;46:102474
pubmed: 32892062
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Neurology. 2020 Aug 25;95(8):e1060-e1070
pubmed: 32482845
Case Rep Neurol Med. 2021 Mar 24;2021:6658000
pubmed: 33833883
Int Med Case Rep J. 2021 May 25;14:349-355
pubmed: 34079389
Neuroophthalmology. 2021 May 24;46(2):115-121
pubmed: 35273416
Front Neurol. 2020 Nov 25;11:598531
pubmed: 33324337
Neurology. 2020 Aug 4;95(5):e601-e605
pubmed: 32303650
J Neuroimmunol. 2021 Apr 15;353:577521
pubmed: 33607505
Mult Scler Relat Disord. 2021 May;50:102857
pubmed: 33647592
Mult Scler. 2020 Jun;26(7):806-814
pubmed: 31094288
Neurol Neuroimmunol Neuroinflamm. 2021 Aug 27;8(6):
pubmed: 34452974
N Engl J Med. 2020 Jun 25;382(26):2574-2576
pubmed: 32302082
J Neuroophthalmol. 2020 Sep;40(3):398-402
pubmed: 32604245
Front Immunol. 2021 Apr 26;12:653786
pubmed: 33981305
Sci Transl Med. 2020 Nov 18;12(570):
pubmed: 33139519
Ther Adv Neurol Disord. 2020 Aug 30;13:1756286420952901
pubmed: 32944082
Indian J Pediatr. 2021 May;88(5):488-489
pubmed: 33471314
Hosp Pediatr. 2020 Jun;10(6):537-540
pubmed: 32265235